Granules India has acquired Swiss CDMO company Senn Chemicals AG for Rs 192 crore, expanding its peptide therapeutics market presence. The move enhances Granules' CDMO capabilities, leveraging Senn's peptide synthesis expertise for global solutions. The acquisition is set to be finalized by the first half of 2025.